SMARCA4 deficiency is associated with undifferentiated thoracic carcinoma33–35 and 3q gain is a characteristic feature of lung squamous cell carcinoma (LUSC) rather than LUAD36. Here, SMARCA4 is linked to squamous cell lung carcinoma.